David Tester

Mayo Clinic Academic Setting

Author of 8 ePosters

 eCatalog Module
Basic/Translational Science -> Cell Physiology, Pharmacology, and Signaling D-AB03 - Inherited arrhythmic disorders: new approaches for understanding of mechanisms and experimental therapies (ID 5) Abstract
No eCatalog Preview Available

D-AB03-04 - The Awe And Worry Of Lumacaftor Pharmacological Rescue For Patients With Type 2 Long Qt Syndrome Stemming From Trafficking Defective Kv11.1 Mutations (ID 1404)

Authors
Disclosure
 D. Tester: Nothing relevant to disclose.
Pediatric/Adult Congenital Heart Disease -> Pediatric Cardiology D-AB17 - Fetal Inherited [Congenital] Syndrome (ID 8) Abstract
No eCatalog Preview Available

D-AB17-05 - Disease Modeling And Lumacaftor Drug Efficacy Testing In Ipsc-cms Derived From A Patient With A Novel Kcnh2 Variant Of Uncertain Significance (ID 1415)

Authors
Disclosure

 B.J. O'Hare: Nothing relevant to disclose.

Video File Upload
Basic/Translational Science -> Genomics: Translational D-AB19 - Basic Science: What Lies Beneath (ID 20) Abstract
No eCatalog Preview Available

D-AB19-01 - Phenotype-guided Whole Genome Analysis In A Patient With Genetically Elusive Long Qt Syndrome Yields A Novel Trdn-Encoded Triadin Pathogenetic Substrate For Triadin Knockout Syndrome And Reveals A Novel Primate-specific Cardiac Trdn Transcript (ID 779)

Authors
Disclosure
 D.J. Clemens: Nothing relevant to disclose.
Basic/Translational Science -> Cell Physiology, Pharmacology, and Signaling D-PO01 - Featured Poster Session (ID 11) Poster
No eCatalog Preview Available

D-PO01-208 - Characterization Of The Cellular And Electrophysiological Phenotype Of Triadin Knockout Syndrome Using Human Induced Pluripotent Stem Cell-derived Cardiomyocytes (ID 966)

Authors
Disclosure
 D.J. Clemens: Nothing relevant to disclose.
Basic/Translational Science -> Cell Physiology, Pharmacology, and Signaling D-PO02 - Poster Session II (ID 47) Poster
No eCatalog Preview Available

D-PO02-026 - Characterization Of The Calcium Release Channel Deficiency Syndrome Secondary To A Homozygous, Multi-exon Duplication In Ryr2 (ID 985)

Authors
Disclosure
 D. Tester: Nothing relevant to disclose.
Basic/Translational Science -> Genomics: Translational D-PO03 - Poster Session III (ID 48) Poster
No eCatalog Preview Available

D-PO03-025 - CRISP/Cas9 And AKAP9-S1570l Patient-specific Induced Pluripotent Stem Cell-derived Cardiomyocytes: New Evidence To Challenge Clingen’s “Limited Evidence” Designation For AKAP9-Encoded Yotiao As A Long QT Syndrome Susceptibility Gene (ID 277)

Authors
Disclosure
 D. Ye: Nothing relevant to disclose.
Clinical Electrophysiology -> SCA Risk Assessment: -> Clinical Risk Assessment Techniques D-PO04 - Poster Session IV (ID 15) Poster

D-PO04-217 - Artificial Intelligence-guided Risk Stratification In Congenital Long Qt Syndrome (ID 1239)

Authors
Disclosure
 K.L. Turkowski: Nothing relevant to disclose.
Cardiac Genetics -> Genetic Testing and genomics D-PO05 - Poster Session V (ID 39) Poster

D-PO05-077 - Patients With Hypertrophic Cardiomyopathy Deemed Genotype Negative Based On Research Grade Genetic Analysis: Time For Repeat Diagnostic Testing With Next Generation Sequencing (ID 1259)

Authors
Disclosure
 B.J. O'Hare: Nothing relevant to disclose.